These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 898119

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The treatment with L-dopa and amantadine in Parkinson's disease.
    Pendefunda G, Pollingher B, Stefanache F, Gavril A, Oprisan C, Merling M, Nemteanu E, Ciunru M, Koropitzer I.
    Ther Hung; 1975; 23(1):12-6. PubMed ID: 1105871
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F, Grünberger J, Oberhummer I.
    Wien Med Wochenschr; 1971 May 08; 121(19):390-7. PubMed ID: 5559920
    [No Abstract] [Full Text] [Related]

  • 5. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)].
    Gerstenbrand F, Grünberger J, Oberhummer I.
    HNO; 1970 Nov 08; 18(11):390-7. PubMed ID: 5512006
    [No Abstract] [Full Text] [Related]

  • 6. [The additive effect of amantadine hydrochloride (Symmetrel) on parkinsonian patients receiving levodopa treatment (author's transl)].
    Shiozawa R, Kase M, Kuroiwa Y, Narabayashi H, Nishitani Y, Ohmoto T, Toyokura Y, Uono K.
    No To Shinkei; 1981 Mar 08; 33(3):301-9. PubMed ID: 7018522
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy: problems and practices.
    Muenter MD.
    Clin Neuropharmacol; 1986 Mar 08; 9 Suppl 1():S23-36. PubMed ID: 3708606
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A, Grau-Veciana JM.
    Med Clin (Barc); 1985 Jun 15; 85(3):88-91. PubMed ID: 4021630
    [No Abstract] [Full Text] [Related]

  • 13. Controlled trial of amantadine hydrochloride in Parkinson's disease.
    Jorgensen PB, Bergin JD, Haas L, Cuningham JA, Morah DD, Pollock M, Robinson RG, Spears GF.
    N Z Med J; 1971 May 15; 73(468):263-7. PubMed ID: 4932146
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Update on the treatment of Parkinson's disease.
    Wirz D.
    Conn Med; 1985 Oct 15; 49(10):633-7. PubMed ID: 3933903
    [No Abstract] [Full Text] [Related]

  • 16. Parkinson's disease.
    Morley JB.
    Aust Fam Physician; 1977 Jan 15; 6(1):29-30, 32, 34-5. PubMed ID: 16582
    [Abstract] [Full Text] [Related]

  • 17. In practice. Parkinson's disease.
    Hill JW.
    N Z Med J; 1979 Oct 10; 90(645):300-4. PubMed ID: 229444
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacology of Parkinson's disease.
    Burton K, Calne DB.
    Neurol Clin; 1984 Aug 10; 2(3):461-72. PubMed ID: 6152482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.